학술논문
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
Document Type
Article
Author
Source
In iScience 15 July 2022 25(7)
Subject
Language
ISSN
2589-0042